Since the PI3K-Akt was already identified through Pathview/DAVID, and “Pathways in cancer” was one of processes annotated for ‘gamma’ comparisons, it was decided to include “MicroRNAs in cancer” for both ‘alpha’ and ‘gamma’ comparisons and “Pathways in cancer” for the ‘alpha’ comparison. Here, PIK3CB is linked to cancer.